Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Long-Term Investments came in at $1.3 million in Q1 2026, up 2.71% year-on-year from $1.3 million in Q1 2025, and little changed on a QoQ basis from $1.3 million in Q4 2025.
Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Long-Term Investments data on file, last reported at $1.3 million in Q1 2026.
- On a quarterly basis, Long-Term Investments rose 2.71% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 2.71% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 2.56% from the prior year.
- Long-Term Investments for Q1 2026 stood at $1.3 million, roughly flat from $1.3 million in the prior quarter.
- Over the last five years, Long-Term Investments for SLGL reached as high as $1.3 million in Q1 2026 and fell as low as $1.3 million in Q1 2024.
- Historically, Long-Term Investments has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
- Across the five-year window, Long-Term Investments retreated 2.47% in 2024 and gained 2.75% in 2025, its largest moves.
- Year by year, Long-Term Investments stood at $1.3 million in 2022, then dropped by 0.31% to $1.3 million in 2023, then climbed by 0.55% to $1.3 million in 2024, then increased by 2.56% to $1.3 million in 2025, then rose by 0.3% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.29 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 1.29 Mn |